According to Zhitong Finance App News, Cube Pharmaceuticals (003020.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 334 million yuan, a year-on-year decrease of 58.90%; net profit attributable to shareholders of listed companies was 30.372,200 yuan, a year-on-year decrease of 54.08%; net profit attributable to shareholders of listed companies deducted non-recurring profit and loss of 28.3984 million yuan, a year-on-year decrease of 56.38%; basic earnings per share were 0.19 yuan/share.